Bisker-Leib Vered

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Bisker-Leib Vered's trades of Compass Therapeutics, Inc.'s stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-11-25 2022-11-25 S Sale
67,046 +46.7%
308.66
US$2,894,331
67,046 +46.7% 308.66 US$2,894,331
2022-11-25 2022-11-23 S Sale
12,231 +6.5%
223.43
US$4,446,907
12,231 +6.5% 223.43 US$4,446,907
2022-11-25 2022-11-22 S Sale
2,613 -25.5%
486.95
US$3,137,668
2,613 -25.5% 486.95 US$3,137,668
2022-11-22 2022-11-21 S Sale
16,035 -1.5%
4.34
US$69,592
16,035 -1.5% 4.34 US$69,592
2022-11-22 2022-11-18 S Sale
6,226 -0.6%
4.40
US$27,394
6,226 -0.6% 4.40 US$27,394